Trending...
- Dizengoff and Yost Launch Digital Sign in Hammonton NJ - 192
- NaturismRE Launches the 11 Levels of Naturism: A Groundbreaking Framework Guiding the Global Naturist Journey
- K2 Integrity and Sonata One Partner to Accelerate Capital Raising, Reduce Risk, and Deliver Scalable Advisory Services for Private Fund Managers
This CME Symposium takes place on Wednesday, April 30, 2025, from 8:00-9:30 PM PT during Asembia's AXS25 Summit at the Wynn Las Vegas in Las Vegas, Nevada.
HAZLET, N.J. - JerseyDesk -- In this educational initiative, to take place at the 2025 AXS Specialty Pharmacy meeting, a multidisciplinary faculty—consisting of two hyperkalemia experts in heart failure (one cardiologist, Dr. Stephen Greene and one pharmacist, Dr. Robert Page) and two hyperkalemia experts in chronic kidney disease (one nephrologist, Dr. Csaba Kovesdy and one pharmacist, Dr. Joanna Hudson) will explain the cardiovascular risks associated with discontinuing/reducing the dose of RAASi therapy due to hyperkalemia and the clinical evidence with novel potassium binders for reducing serum potassium and facilitating maintenance of RAASi therapy. Roles of specialty pharmacists in the management of patients with hyperkalemia will be identified, and clinical practice pearls will be described. A case presentation and faculty discussion of a patient with HF, CKD and hyperkalemia at high cardiorenal risk will provide attendees with best practices and key take-home messages.
More on Jersey Desk
This program is jointly provided by Postgraduate Institute for Medicine and Voxmedia LLC.
Click here for more information and to register
CO-CHAIRS
Joanna Hudson, PharmD, BCPS
Professor
Departments of Clinical Pharmacy and Translational Science & Medicine (Nephrology)
The University of Tennessee Health Science Center
Memphis, Tennessee
Robert Page, PharmD, MSPH, BCPS, BCGP
Professor
Departments of Clinical Pharmacy and Physical Medicine
Skaggs School of Pharmacy and Pharmaceutical Sciences
CU Anschutz
Aurora, Colorado
FACULTY
Stephen Greene, MD
Associate Professor of Medicine
Duke University School of Medicine
Duke Clinical Research Institute
Durham, North Carolina
Csaba Kovesdy, MD
Fred Hatch Professor of Medicine
University of Tennessee Health Science Center
Memphis VA Medical Center
Memphis, Tennessee
Educational Objectives:
Target Audience
More on Jersey Desk
This educational activity is intended for Pharmacists.
Educational Grant
Voxmedia International gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA4008162-9999-25-091-L01-P)
Type of Activity: Knowledge
More on Jersey Desk
- Corner Property Management Welcomes Eatonbrook Cooperative to Its Growing Portfolio
- New Professional Association to Study Principles of Hospitality Applied to the Delivery of Healthcare
- Clinical Endpoints Successfully Met in Study for Groundbreaking 12-Lead ECG Synthesis Technology Allowing Software Application to FDA: HeartBeam, Inc
- Boston Industrial Solutions, Inc. Unveils Natron® 504N UV LED Inks Designed for EPSON Printheads
- Kavelle Christie: Trump's First 100 Days Mark Alarming Breakdown in Healthcare, Public Health, and Freedoms
This program is jointly provided by Postgraduate Institute for Medicine and Voxmedia LLC.
Click here for more information and to register
CO-CHAIRS
Joanna Hudson, PharmD, BCPS
Professor
Departments of Clinical Pharmacy and Translational Science & Medicine (Nephrology)
The University of Tennessee Health Science Center
Memphis, Tennessee
Robert Page, PharmD, MSPH, BCPS, BCGP
Professor
Departments of Clinical Pharmacy and Physical Medicine
Skaggs School of Pharmacy and Pharmaceutical Sciences
CU Anschutz
Aurora, Colorado
FACULTY
Stephen Greene, MD
Associate Professor of Medicine
Duke University School of Medicine
Duke Clinical Research Institute
Durham, North Carolina
Csaba Kovesdy, MD
Fred Hatch Professor of Medicine
University of Tennessee Health Science Center
Memphis VA Medical Center
Memphis, Tennessee
Educational Objectives:
- Recognize hyperkalemia as a frequent, treatable, and manageable side effect of optimal therapy for HF and CKD
- Explain the relationship between down-titration or discontinuation of RAASi therapy and clinical outcomes • Interpret the clinical evidence for novel potassium binders in the treatment of hyperkalemia
- Identify the multiple roles of the specialty pharmacist in managing the patient with HF and/or CKD with, or at high risk for hyperkalemia
Target Audience
More on Jersey Desk
- Hexaware Delivers Strong Q1CY25 Revenue at $371.5 Mn Up 12.4% YoY USA - English India - English
- Caldwell University's Ashleigh Tavaska Named CACC Softball Player of the Year
- OpenSSL Technical Advisory Committee Elections Now Open – Cast Your Vote
- Axiros Confirms Continued Compliance with ISO/IEC 27001:2022 After Surveillance Audit
- Twitter's Buzzing! What's the Deal with PhotoG, the AI Everyone's Talking About?
This educational activity is intended for Pharmacists.
Educational Grant
Voxmedia International gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA4008162-9999-25-091-L01-P)
Type of Activity: Knowledge
Source: CMEPlanet
Filed Under: Education
0 Comments
Latest on Jersey Desk
- Inaugural User Group Meeting for HealthTech Innovators Hosted By GD
- Charleston, SC - ACSEC offers Rain Barrels Through Annual Program
- Greek Government Issues Landmark Ministerial Order Addressing Citizenship of Greek-born adoptees
- Baltimore Author Crafts Space Opera Where Human Questions Outshine Galactic Scale
- Stout Surpasses 60,000 Acres and 3 Billion Plants Scanned
- Benjamin Ross Group, LLC Sells Renovation Company, Monmouth County, NJ
- OpsVeda Announces Launch of TariffSight, the World's First Comprehensive Platform to Address Tariff-Driven Challenges
- MAJOR New release of Krypto500 (ELF-HF) Sigint - COMINT software
- New Build-to-Suit VA Medical Office Facility Coming to Highland Heights, KY
- Marketing Mastery in the Urban Landscape Ignites a New Wave of Bold, Brand-Ready Businesses
- Fairfield Inn by Marriott Scottsdale Old Town Opens
- InventHelp Inventor Develops New Game to Promote Exercise (NJR-107)
- Pelican Reef Group Announces Grand Opening of New High Point Showroom – IHFC Building H-621 & Event April 27th, 2025
- NaturismRE Launches the 11 Levels of Naturism: A Groundbreaking Framework Guiding the Global Naturist Journey
- K2 Integrity and Sonata One Partner to Accelerate Capital Raising, Reduce Risk, and Deliver Scalable Advisory Services for Private Fund Managers
- The World's No.1 Superstar™ Walks Where Legends Rest: A Sacred Encounter in Rome Before the Pope's Passing
- Coming Up on "Financial Freedom with Tom Hegna" Financial Expert Parker Faulkner
- Tobu Railway Announces a Price Revision on the "NIKKO PASS All Area" and "NIKKO PASS World Heritage Area," from April 20, 2025
- Kemeny, Ramp & Renaud, LLC Welcomes Prominent Trusts and Estates Attorney Gary B. Cornick to Its Firm
- Appointments Now Open for New Townhome Releases at Heritage at South Brunswick